Error: Could not add to watchlist. X

Anthera Pharmaceuticals Inc

+ Watchlist
ANTH:US
NASDAQ GM
8.62
USD
0.88
11.37%
As of 19:40:00 ET on 06/30/2015.
Open
7.90
Day Range
7.80 - 8.64
Volume
1,056,064
Previous Close
7.74
52Wk Range
1.46 - 9.89
1 Yr Return
152.05%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.22
Market Cap (m USD)
308.737
Shares Outstanding (m)
35.816
Price/Sales (TTM)
970.90
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Anthera Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic fibrosis.
ADDRESS
25801 Industrial Boulevard
Suite B
Hayward, CA 94545
United States
PHONE
1-510-856-5600
  • Paul F Truex
    President/CEO/Founder
  • Debra Odink
    Senior VP/CTO
  • Colin Hislop
    Senior VP/Chief Medical Ofcr
  • Klara A Dickinson-Eason
    Senior VP/Chief Regulatory Ofcr
  • May Liu
    Senior VP:Finance & Administration
Show More